Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07806695
PHASE1
Islet Function in Gestational Diabetes
Sponsor: Mayo Clinic
View on ClinicalTrials.gov
Summary
The purpose of this research is to understand how the function of the human pancreas changes during and after pregnancy.
Key Details
Gender
FEMALE
Age Range
20 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
90
Start Date
2026-09
Completion Date
2030-12
Last Updated
2026-09-08
Healthy Volunteers
No
Conditions
Interventions
DRUG
Exendin 9-39
Exendin 9-39 will be administered during one postpartum study day as an intravenous infusion at 300 pmol/kg/min for 4 hours, beginning 60 minutes before the graded glucose infusion and continuing through the end of the 180-minute glucose infusion study period
Locations (1)
Mayo Clinic
Rochester, Minnesota, United States